ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0217

Development of the American College of Rheumatology Implementation Guide for Integrating Patient Reported Systemic Lupus Erythematosus Quality Measures

Catherine Nasrallah1, Christine Hariz2, Shanthini Kasturi3, Wambui Machua4, Jinoos Yazdany5, Christie Bartels6, Kate Chiseri7, Starla Blanks7, Patti Katz8, Cherish Wilson9, April Jorge10, Beth Radtke11, Tom Tack7 and Shivani Garg12, 1University of California San Francisco (UCSF), San Francisco, CA, 2University of California San Francisco (UCSF, San Francisco, CA, 3Tufts Medical Center, Boston, MA, 4Piedmont Healthcare, Atlanta, GA, 5UCSF, San Francisco, CA, 6University of Wisconsin School of Medicine and Public Health, Madison, WI, 7American College of Rheumatology, Atlanta, GA, 8UCSF, San Rafael, CA, 9UCSF / SFVA, San Francisco, CA, 10Massachusetts General Hospital, Boston, MA, 11ACR, Atlanta, GA, 12University of Madison, School of Medicine and Public Health, Madison, WI

Meeting: ACR Convergence 2025

Keywords: depression, Outcome measures, physical function, Qualitative Research, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0210–0232) Measures & Measurement of Healthcare Quality Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a complex disease that presents unique care challenges. To improve high-quality patient-centered care, the American College of Rheumatology (ACR), developed evidence-based quality measures related to using patient reported outcome measures (PROMs) in SLE. This study aimed: 1) To conduct qualitative interviews with practices that had implemented ACR-recommended SLE PROMs as part of the pilot evaluation, using the Consolidated Framework for Implementation Research (CFIR) and 2) To synthesize implementation findings to inform the development of the SLE Quality Measures Implementation Guide for national dissemination.

Methods: Using purposive sampling, we invited five community-based rheumatology practices representing geographically diverse clinical settings to pilot the routine collection of SLE PROMs, including measures of physical function (RAPID-3 or MDHAQ) and depression (PHQ-8). After the pilot, rheumatologists and medical staff from each practice participated in qualitative virtual interviews, guided by the CFIR, to identify barriers and facilitators to implementing SLE PROMs and explore resources needed to improve the collection and use of the measures in clinical care. Recorded interviews were transcribed and analyzed thematically using deductive and inductive techniques to identify themes. Subsequently, insights from interviews, combined with ACR guidelines and other resources, informed the development of an SLE Quality Measures Implementation Guide (Figure 1).

Results: Thirty-one clinicians engaged in the pilot evaluation across five practices (Table 1). Qualitative Interviews with representatives from each practice (N&#3f8) revealed key insights into the innovations, resources, recommendations, best practices, and challenges related to SLE PROMs collection and use (Table 2). Despite challenges with workflow integration, clinician and medical staff engagement, and limited resources, both patients and clinicians supported using PROMs in routine care. PROMs effectively assessed mental health and physical function through standardized workflows, enhanced communication, and EHR integration. These findings informed the development of an online SLE Quality Measures Implementation Guide, designed to aide clinicians and care teams with implementing the recommended measures into clinical practice. Sections include recommended detailed instructions for use of ACR-recommended SLE PROMs, downloadable PROMs, workflow recommendations and scoring guidance. Reflecting themes from interviews, the guide also includes videos on best practices, patient education materials, staff training resources, and validated translations of PROMs in Spanish and Chinese.

Conclusion: This study assessed the implementation of ACR-recommended SLE PROMs in five rheumatology practices and used the findings to develop the SLE Quality Measures Implementation Guide. This guide supports rheumatologists and care teams with integrating PROMs into routine practice by offering guidance and practical strategies for collecting the measures to guide clinical decisions and advance patient-centered care.

Supporting image 1Figure1: Workflow for Developing the SLE Implementation Guide

Supporting image 2Table 1. Characteristics of Pilot Practices.

Supporting image 3Table 2: Barriers and Opportunities of SLE PROMs Collection: Findings from Qualitative Interviews


Disclosures: C. Nasrallah: None; C. Hariz: None; S. Kasturi: GlaxoSmithKlein(GSK), 1; W. Machua: Aurinia, 2, BMS Foundation, 5, Genentech, 2, GlaxoSmithKlein(GSK), 2, 6, Janssen, 1; J. Yazdany: AstraZeneca, 2, Aurinia, 5, Gilead, 5; C. Bartels: None; K. Chiseri: None; S. Blanks: None; P. Katz: None; C. Wilson: None; A. Jorge: Bristol-Myers Squibb(BMS), 5; B. Radtke: None; T. Tack: None; S. Garg: None.

To cite this abstract in AMA style:

Nasrallah C, Hariz C, Kasturi S, Machua W, Yazdany J, Bartels C, Chiseri K, Blanks S, Katz P, Wilson C, Jorge A, Radtke B, Tack T, Garg S. Development of the American College of Rheumatology Implementation Guide for Integrating Patient Reported Systemic Lupus Erythematosus Quality Measures [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/development-of-the-american-college-of-rheumatology-implementation-guide-for-integrating-patient-reported-systemic-lupus-erythematosus-quality-measures/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-the-american-college-of-rheumatology-implementation-guide-for-integrating-patient-reported-systemic-lupus-erythematosus-quality-measures/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology